-+ 0.00%
-+ 0.00%
-+ 0.00%

TELOMIR PHARMACEUTICALS SELECTS LINICAL TO ADVANCE FDA-CLEARED PHASE 1/2 CLINICAL TRIAL OF TELOMIR-ZN IN TRIPLE-NEGATIVE BREAST CANCER

Reuters·11/18/2026 13:01:09